Review article: The clinical pharmacology of proton pump inhibitors

322Citations
Citations of this article
350Readers
Mendeley users who have this article in their library.

Abstract

Proton pump inhibitors inhibit the gastric H+/K+-ATPase via covalent binding to cysteine residues of the proton pump. All proton pump inhibitors must undergo acid accumulation in the parietal cell through protonation, followed by activation mediated by a second protonation at the active secretory canaliculus of the parietal cell. The relative ease with which these steps occur with different proton pump inhibitors underlies differences in their rates of activation, which in turn influence the location of covalent binding and the stability of inhibition. Slow activation is associated with binding to a cysteine residue involved in proton transport that is located deep in the membrane. However, this is inaccessible to the endogenous reducing agents responsible for restoring H+/K+-ATPase activity, favouring a longer duration of gastric acid inhibition. Pantoprazole and tenatoprazole, a novel proton pump inhibitor which has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors, are activated more slowly than other proton pump inhibitors but their inhibition is resistant to reversal. In addition, tenatoprazole has a greatly extended plasma half-life in comparison with all other proton pump inhibitors. The chemical and pharmacological characteristics of tenatoprazole give it theoretical advantages over benzimidazole-based proton pump inhibitors that should translate into improved acid control, particularly during the night. © 2006 The Authors.

References Powered by Scopus

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

569Citations
N/AReaders
Get full text

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

418Citations
N/AReaders
Get full text

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trial

416Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals

4647Citations
N/AReaders
Get full text

The resurgence of covalent drugs

1443Citations
N/AReaders
Get full text

An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles

733Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sachs, G., Shin, J. M., & Howden, C. W. (2006). Review article: The clinical pharmacology of proton pump inhibitors. In Alimentary Pharmacology and Therapeutics (Vol. 23, pp. 2–8). https://doi.org/10.1111/j.1365-2036.2006.02943.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 112

72%

Professor / Associate Prof. 20

13%

Researcher 20

13%

Lecturer / Post doc 4

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 74

42%

Pharmacology, Toxicology and Pharmaceut... 52

29%

Chemistry 26

15%

Biochemistry, Genetics and Molecular Bi... 26

15%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 1
References: 4
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free